125 related articles for article (PubMed ID: 33111465)
1. Iron overload after allogeneic stem cell transplantation in children with acute lymphoblastic leukemia.
Salmi A; Holmström M; Toiviainen-Salo S; Kanerva J; Taskinen M
Pediatr Transplant; 2020 Dec; 24(8):e13846. PubMed ID: 33111465
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Evaluation of Relationship Between Iron Overload and Transplantation Complications in Pediatric Patient Who Underwent Allogeneic Stem Cell Transplantation Due to Acute Leukemia and Myelodysplastic Syndrome.
Küpesiz FT; Hazar V; Eker N; Guler E; Yesilipek MA; Tuysuz G; Kupesiz A
J Pediatr Hematol Oncol; 2020 Jul; 42(5):e315-e320. PubMed ID: 32427707
[TBL] [Abstract][Full Text] [Related]
3. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.
Armand P; Kim HT; Rhodes J; Sainvil MM; Cutler C; Ho VT; Koreth J; Alyea EP; Hearsey D; Neufeld EJ; Fleming MD; Steen H; Anderson D; Kwong RY; Soiffer RJ; Antin JH
Biol Blood Marrow Transplant; 2011 Jun; 17(6):852-60. PubMed ID: 20854920
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging diagnosis of iron overload in a leukemic patient after allogeneic hematopoietic stem cell transplantation.
Tan CH; Marcal L; Tan D; Patnana M
Transfusion; 2010 May; 50(5):1113-7. PubMed ID: 20070618
[TBL] [Abstract][Full Text] [Related]
5. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.
Chotsampancharoen T; Gan K; Kasow KA; Barfield RC; Hale GA; Leung W
Pediatr Transplant; 2009 May; 13(3):348-52. PubMed ID: 18518909
[TBL] [Abstract][Full Text] [Related]
6. Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases.
Cattoni A; Capitoli G; Casagranda S; Corti P; Adavastro M; Molinaro A; Di Gennaro F; Bonanomi S; Biondi A; Galimberti S; Balduzzi A
Transplant Cell Ther; 2023 Apr; 29(4):271.e1-271.e12. PubMed ID: 36708803
[TBL] [Abstract][Full Text] [Related]
7. Number of erythrocyte transfusions is more predictive than serum ferritin in estimation of cardiac iron loading in pediatric patients with acute lymphoblastic leukemia.
Unal S; Cetin M; Hazirolan T; Yildirim G; Meral A; Birbilen A; Karabulut E; Aytac S; Tavil B; Kuskonmaz B; Tuncer M; Gumruk F
Leuk Res; 2014 Aug; 38(8):882-5. PubMed ID: 24933623
[TBL] [Abstract][Full Text] [Related]
8. Iron Overload in Survivors of Childhood Cancer.
Schempp A; Lee J; Kearney S; Mulrooney DA; Smith AR
J Pediatr Hematol Oncol; 2016 Jan; 38(1):27-31. PubMed ID: 26422286
[TBL] [Abstract][Full Text] [Related]
9. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Liver Iron Content by Magnetic Resonance Imaging in Children with Acute Lymphoblastic Leukemia after Cessation of Treatment.
Acar S; Gözmen S; Bayraktaroğlu S; Acar SO; Tahta N; Aydınok Y; Vergin RC
Turk J Haematol; 2020 Nov; 37(4):263-270. PubMed ID: 32077272
[TBL] [Abstract][Full Text] [Related]
11. Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content.
Trottier BJ; Burns LJ; DeFor TE; Cooley S; Majhail NS
Blood; 2013 Aug; 122(9):1678-84. PubMed ID: 23777771
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study.
Sirvent A; Auquier P; Oudin C; Bertrand Y; Bohrer S; Chastagner P; Poirée M; Kanold J; Thouvenin S; Perel Y; Plantaz D; Tabone MD; Yakouben K; Gandemer V; Lutz P; Sirvent N; Vercasson C; Berbis J; Chambost H; Leverger G; Baruchel A; Michel G
Bone Marrow Transplant; 2017 Jan; 52(1):80-87. PubMed ID: 27595286
[TBL] [Abstract][Full Text] [Related]
13. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
Goto T; Ikuta K; Inamoto Y; Kamoshita S; Yokohata E; Koyama D; Onodera K; Seto A; Watanabe K; Imahashi N; Tsukamoto S; Ozawa Y; Sasaki K; Ito M; Kohgo Y; Miyamura K
Int J Hematol; 2013 Jan; 97(1):125-34. PubMed ID: 23264147
[TBL] [Abstract][Full Text] [Related]
14. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
[TBL] [Abstract][Full Text] [Related]
15. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.
Akı ŞZ; Suyanı E; Cengiz M; Özenirler S; Elbeğ Ş; Paşaoğlu H; Sucak GT
Biol Blood Marrow Transplant; 2015 May; 21(5):948-53. PubMed ID: 25681034
[TBL] [Abstract][Full Text] [Related]
16. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
Majhail NS; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
Majhail NS; DeFor T; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
[TBL] [Abstract][Full Text] [Related]
19. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
Inati A; Kahale M; Sbeiti N; Cappellini MD; Taher AT; Koussa S; Nasr TA; Musallam KM; Abbas HA; Porter JB
Pediatr Blood Cancer; 2017 Jan; 64(1):188-196. PubMed ID: 27576370
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT).
Sivgin S; Eser B; Bahcebasi S; Kaynar L; Kurnaz F; Uzer E; Pala C; Deniz K; Ozturk A; Cetin M; Unal A
Ann Hematol; 2012 May; 91(5):743-749. PubMed ID: 22051904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]